![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 23, 21706-21712, June 10, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

¶

||

From the
Department of Biology, McMaster University, 1280 Main St. West, Hamilton, Ontario L8S 4K1, Canada,
School of Medicine, The University of Leeds, Leeds LS2 9JT, United Kingdom, and **Faculty of Life Sciences, The University of Manchester, G.38 Stopford Building, Oxford Road, Manchester M13 9PT, United Kingdom
The incidence of Alzheimer disease is increased following ischemic episodes, and we previously demonstrated that following chronic hypoxia (CH), amyloid
(A
) peptide-mediated increases in voltage-gated L-type Ca2+ channel activity contribute to the Ca2+ dyshomeostasis seen in Alzheimer disease. Because in certain cell types mitochondria are responsible for detecting altered O2 levels we examined the role of mitochondrial oxidant production in the regulation of recombinant Ca2+ channel
1C subunits during CH and exposure to A
-(140). In wild-type (
+) HEK 293 cells expressing recombinant L-type
1C subunits, Ca2+ currents were enhanced by prolonged (24 h) exposure to either CH (6% O2) or A
-(140) (50 nM). By contrast the response to CH was absent in
0 cells in which the mitochondrial electron transport chain (ETC) was depleted following long term treatment with ethidium bromide or in
+ cells cultured in the presence of 1 µM rotenone. CH was mimicked in
0 cells by the exogenous production of
. by xanthine/xanthine oxidase. Furthermore A
-(140) enhanced currents in
0 cells to a degree similar to that seen in cells with an intact ETC. The antioxidants ascorbate (200 µM) and Trolox (500 µM) ablated the effect of CH in
+ cells but were without effect on A
-(140)-mediated augmentation of Ca2+ current in
0 cells. Thus oxidant production in the mitochondrial ETC is a critical factor, acting upstream of amyloid
peptide production in the up-regulation of Ca2+ channels in response to CH.
Received for publication, March 22, 2005 , and in revised form, April 6, 2005.
* Equipment was provided by New Opportunities grants (to I. M. F.) from the Canada Foundation for Innovation (Grant 7400) and the Ontario Innovation Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Supported by the British Heart Foundation.
|| Supported by the British Heart Foundation, The Medical Research Council, The Alzheimer's Research Trust, and the Alzheimer's Society.

Supported by Grant-in-aid NA 5230 from the Heart and Stroke Foundation of Ontario. To whom correspondence should be addressed. Tel.: 44-161-275-5496; Fax: 44-161-275-5600; E-mail: ian.fearon{at}manchester.ac.uk.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
I. M. Fearon OxLDL enhances L-type Ca2+ currents via lysophosphatidylcholine-induced mitochondrial reactive oxygen species (ROS) production Cardiovasc Res, March 1, 2006; 69(4): 855 - 864. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |